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ABSTRACT 
Objective: To evaluate the diuretic and antiurolithiatic properties of ethanolic extract of Sida acuta Burm. f. in albino rats. 
Methods: Three different doses of Sida acuta (100 mg/kg, 200 mg/kg, 400 mg/kg) were tested for diuretic activity and compared with furosemide (25 
mg/kg) and control group. 24 hr urine output and urinary concentrations of sodium (Na+), potassium (K+) and chloride (Cl-) ions were the parameters 
measured. Prophylactic and curative antiurolithiatic activity was tested for three doses (100 mg/kg, 200 mg/kg & 400 mg/kg) of Sida acuta and 
compared with control group and animals treated with standard herbal preparation Cystone (750 mg/kg) using zinc disc implantation model. 
Results: Sida acuta (400 mg/kg) significantly increased the urine output (p<0.001), which was almost equivalent to furosemide. Sida acuta also 
caused a significant increase in the excretion of K+ and Cl-at higher doses (200 mg/kg, 400 mg/kg). Effects on Na+excretion were not significant for 
all three doses of the test drug. Sida acuta (200 mg/kg, 400 mg/kg) showed statistically significant (p<0.05) reduction in depositions around zinc 
discs as compared to control when tested in prophylactically treated rats, but not in rats treated post-urolithiasis induction. 
Conclusion: Sida acuta produced a dose-dependent increase in urine output, with no effect on sodium excretion. This probably indicates that the 
diuresis produced could be due to its aquarectic action. It also showed significant prophylactic antiurolithiatic activity, but further studies are 
necessary to evaluate fully its therapeutic potential. 
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INTRODUCTION 
Urolithiasis has been one of the oldest medical conditions known to 
mankind. It refers to the formation of stone anywhere in the urinary 
tract and is the third most common condition of the urinary tract. 
Current global estimates show that urolithiasis affects around 12% 
of the population, with the recurrence rate being 70-80% in males 
and 47-60% in females [1]. Risk of developing urolithiasis is greater 
in the Western Hemisphere as compared to the east [2]. Calcium 
oxalate (CaOx) stones are the most predominant variety 
encountered [1]. Size and location of the stone dictates the 
therapeutic modality utilized for managing urolithiasis. Larger 
stones (more than 5 mm) or those which fail to pass through the 
urinary tract spontaneously require interventional procedures such 
as extracorporeal shockwave lithotripsy, percutaneous 
nephrolithotomy, etc. for their removal [3]. However, these 
procedures are expensive, and recurrences are quite common [4]. In 
spite of recent advancements, medical therapy of stone disease is 
limited and there is a dire need for the development of novel 
pharmacological agents in urolithiasis [5]. Moreover, because of its 
high recurrence rate, development of medical prophylactic regimens 
is also necessary [6]. 
Several plant extracts have been used to treat urolithiasis with 
promising effect. Sida acuta Burm. f. has been used in alternative 
systems of medicine to treat various diseases. Leaves of the plant are 
considered to possess demulcent, diuretic, anthelmintic and wound 
healing properties [7]. The roots are considered to possess 
stomachic, diaphoretic, antipyretic, astringent properties and also 
used the treatment of nervous and urinary diseases [8]. In vitro 
studies have shown the inhibitory capacity of methanolic and 
aqueous extracts of the root of Sida acuta on CaOx crystal growth 
[9]. This shows its potential as an antiurolithiatic agent. Many of the 
herbs with antiurolithiatic activity have also been observed to 
possess significant diuretic activity [10]. Diuretic activity, in turn, 
contributes to the antiurolithiatic action of these plants. Increased 
urine output increases the solubility of CaOx and other crystallizing 
salts and thus facilitates removal of small crystals and prevents their 
aggregation and growth [11]. However, a literature search revealed 
that no in vivo studies have been conducted with Sida acuta for 
evaluating these properties. 
Hence, the following study was designed to evaluate the diuretic and 
antiurolithiatic properties of ethanolic extract of Sida acuta in 
Wistar albino rats. 
MATERIALS AND METHODS 
The study was started after obtaining clearance of the Institutional 
Animal Ethics Committee, Kasturba Medical College, Manipal 
(IAEC/KMC/84/2013).  
Chemicals, drugs, and instruments 
Ethylene glycol (Merck, India), Furosemide (Sanofi-Aventis Pharma, 
India), Cystone (Himalaya Herbal Healthcare, Bangalore, India) and 
biochemical kits (Agappe Diagnostics Limited, Ernakulam, India) 
were purchased from authorized retailers. Star 21 Plus Semi Auto-
analyser (Rapid Diagnostics Group, India) was used for the 
biochemical tests. 
Plant material 
The plant material was procured from Udupi, Karnataka, India and 
authenticated by a botanist from Mahatma Gandhi Memorial College, 
Udupi. The roots were shade dried and powdered using a 
mechanical grinder and sieved. 500 ml of 90% ethanol (solvent) was 
taken in a round bottom flask, which was attached to a Soxhlet 
extractor and condenser. 250 g of powdered plant material was 
loaded in a thimble, and placed inside the Soxhlet extractor. The 
extraction was done at 40 °C for 24 h. Then, the extract was 
subjected to water bath evaporation to remove ethanol. The 
concentrate obtained was weighed and stored in desiccators at room 
temperature for further use [12]. 
Three different doses of 100 mg/kg, 200 mg/kg and 400 mg/kg 
were selected for the study as per previously reported data in 
literature [13]. 
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Inbred male albino rats of Wistar strain weighing 150-200g were 
used for the study. The animals were housed under standard 
environmental conditions and were fed with standard pellet feed 
and water ad libitum. 
Diuretic study 
The rats were randomly divided into five groups of six rats each. 
They fasted overnight before the day of the experiment. All the rats 
received 25 ml/kg body weight of normal saline before drug 
administration to impose uniform salt and water load. They then 
received single dose of vehicle (control group), furosemide 20 
mg/kg (standard group) and three different doses (100 mg/kg, 200 
mg/kg, 400 mg/kg) of ethanolic root extract of Sida acuta (test 
groups), prepared in the same volume of vehicle (0.5% 
carboxymethyl cellulose). Immediately after drug administration, 
each rat was kept in a separate metabolic cage under standard 
housing conditions, and urine was collected over the next 24 h. 
During this period, rats had free access to water but not to food. The 
volume of urine collected over 24 h was measured and 
biochemically analysed for sodium, potassium and chloride levels 
using respective kits [14]. 
Calculation of diuretic index, saliuretic index and Na+/K+ratio 
The following formulae were used for the calculation of different 
urinary parameters:  
Diuretic index =
Mean urine volume of the test group




Concentration of electrolyte in urine of the test group





Concentration of Na+in urine of a group
Concentration of K+in urine of the same group
 
Antiurolithiatic study 
Zinc disc implantation model was used for assessment of 
antiurolithiatic activity. Zinc discs were inserted in the urinary 
bladder of rats as per the method described by Vermeulen et al. [15]. 
Before anaesthesia, the rats were orally administered 5 ml of water 
to dilate their urinary bladder for easier identification. They were 
then anaesthetized with a combination of intraperitoneal ketamine 
(80 mg/kg) and xylazine (8 mg/kg). The abdominal skin was shaved 
and cleaned with surgical spirit. After making a suprapubic incision 
and opening the abdomen, the urinary bladder was carefully 
exposed. A small nick was made at the apex of the bladder, and the 
sterile zinc disc (10±2 mg) was carefully inserted into the bladder. 
The bladder was then closed with 1 or 2 stitches using chromic 
catgut (4-0), and then the abdomen was closed in layers. The skin 
was sutured with sterile silk thread. The rats were allowed to 
recover for 1 w during which food and water were given ad libitum. 
Procedure of study 
Three doses (100 mg/kg, 200 mg/kg & 400 mg/kg) of ethanolic 
extract of roots of Sida acuta were tested for antiurolithiatic activity 
and compared with the control group and animals treated with 
standard herbal preparation Cystone [16]. 
The prophylactic activity of Sida acuta against urolithiasis was 
tested in five groups of rats, each containing six rats. After recovery 
following zinc disc insertion, the control group was administered 
1% solution of ethylene glycol in drinking water ad libitum for 4 w. 
Prophylactic treatment group (Standard) received Cystone 750 
mg/kg orally daily along with 1% solution of ethylene glycol in 
drinking water ad libitum for 4 w. Prophylactic treatment groups 
(Test) received three different doses of ethanolic extract of Sida 
acuta (100 mg/kg, 200 mg/kg, 400 mg/kg) orally daily along with 
1% solution of ethylene glycol in drinking water ad libitum for 4 w. 
Curative property was tested in five groups of rats with six rats in 
each group. After recovery following zinc disc insertion, rats in the 
control group were administered 1% solution of ethylene glycol in 
drinking water ad libitum for 4 w followed by water for the next 4 w. 
Curative treatment (Standard) group received 1% solution of 
ethylene glycol in drinking water for 4 w ad libitum followed by 
Cystone 750 mg/kg orally daily for the next 4 w. Test group animals 
received 1% solution of ethylene glycol in drinking water ad libitum 
for 4 w followed by ethanolic extract of Sida acuta, in three doses 
(100 mg/kg, 200 mg/kg, 400 mg/kg) orally daily for the next 4 w. 
At the end of the study period (4 w for prophylactic activity and 8 w 
for the curative property), rats were sacrificed and zinc disc 
implant/vesical calculi collected, weighed and statistically evaluated. 
The difference between initial and final weights indicated the 
amount of stone formed. 
Statistical analysis 
Data was analysed using analysis of variance (ANOVA) in SPSS 
version 20, followed by post hoc Tukey’s test. Skewed data was 
analysed using Mann-Whitney test, preceded by Kruskal-Wallis test 
for significance. p-value less than 0.05 was considered significant. 
RESULTS 
Assessment of diuretic activity 
Table 1 below shows the effect of different drugs on the urine 
output. The reference diuretic, furosemide, significantly increased 
24 hr urine output when compared to control group (p<0.001), the 
diuretic index being 1.64. The test drug (Sida acuta), at a dose 400 
mg/kg, showed a significant increase in urine volume as compared 
to control (p<0.001) and was comparable with furosemide (p = 
0.991). Sida acuta at 100 mg/kg and 200 mg/kg showed an increase 
in urine output which was not statistically significant (p = 0.414, 
0.051 respectively) when compared to control group. The diuretic 
index of Sida acuta 400 mg/kg (1.59) was less than that of 
furosemide (1.64). 
 
Table 1: Effect of Sida acuta root extract on urine output 
Group Urine output (mL/24hr) [mean±SEM] Diuretic index 
Control 9.28±0.34 - 
Furosemide 20 mg/kg 15.22±0.74* 1.64 
Sida acuta 100 mg/kg 11.22±0.95 1.20 
Sida acuta 200 mg/kg 12.50±1.05 1.34 
Sida acuta 400 mg/kg 14.72±0.60* 1.59 
* = p<0.05 as compared to control (One-way ANOVA followed by post-hoc Tukey’s test); n (number of rats) = 6 in each group; Diuretic index = 
Volume of test group/Volume of control group; ANOVA = Analysis of variance; SEM = Standard error of mean 
 
Table 2 shows the effect of furosemide and Sida acuta at varying 
doses on urinary excretion of Na+, K+ and Cl-. Furosemide showed a 
significant increase in sodium (p = 0.002), potassium (p<0.001) and 
chloride (p<0.001) excretion as compared to control. Sida acuta, at 
200 mg/kg and 400 mg/kg, showed significant increase in the 
urinary excretion of potassium (p<0.001 for both) and chloride (p = 
0.043 and p = 0.006 for Sida acuta 200 mg/kg and 400 mg/kg 
respectively) as compared to the control group. However, Sida acuta 
200 mg/kg was less efficacious than furosemide in its potassium 
excretory capacity (p = 0.023). Sodium excretion, on the other 
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hand, was not significantly higher in Sida acuta 200 mg/kg and 
400 mg/kg groups as compared to the control group (p = 0.196 
and p = 0.086 for Sida acuta 200 mg/kg and 400 mg/kg 
respectively). Sida acuta at 100 mg/kg showed a significant increase 
in the excretion of only potassium (p<0.001) when compared with 
control. The effect on sodium (p = 0.807) and chloride (p = 0.071) 
excretion was not statistically significant. Sida acuta 100 mg/kg 
was also significantly less efficacious when compared to 
furosemide in its capacity to excrete sodium (p = 0.022), 
potassium (p = 0.017) and chloride (p = 0.036). There was no 
statistically significant difference between furosemide and Sida 
acuta 400 mg/kg groups in their capacity to excrete Na+, K+ and Cl-. 
Furosemide showed higher saluretic effect as compared to the test 
drug in different doses. 
 
Table 2: Effect of Sida acuta root extract on urinary excretion of sodium, potassium & chloride ions 
Group Na+ (mmol/l) K+ (mmol/l) Cl- (mmol/l) Saluretic index Na+/K+ 
Na+ K+ Cl- 
Control 89.36±5.38 52.82±0.83 82.19±4.88     
Furosemide 20 mg/kg 126.16±6.62*# 93.05±3.15*#¶ 107.45±1.68*# 1.41 1.76 1.31 0.80 
Sida acuta 100 mg/kg 98.54±5.85 82.37±3.10* 94.15±2.02 1.10 1.56 1.15 0.70 
Sida acuta 200 mg/kg 108.17±6.26 82.77±1.10* 95.16±1.83* 1.21 1.57 1.16 0.77 
Sida acuta 400 mg/kg 111.79±5.42 86.00±1.75* 98.8±3.54* 1.25 1.63 1.20 0.77 
* = p<0.05 as compared to control, # = p<0.05 as compared to Sida acuta 100 mg/kg, ¶ = p<0.05 as compared to Sida acuta 200 mg/kg (One-way ANOVA 
followed by post-hoc Tukey’s test); n (number of rats) = 6 in each group; Saluretic index = Concentration of test group/Concentration of control group; 
ANOVA = Analysis of variance; Na+= Sodium, K+= Potassium, Cl-= Chloride; Na+, K+, Cl-values expressed as mean±Standard error of mean 
 
Assessment of antiurolithiatic activity 
Table 3 shows the effect of different treatment groups on 
prophylactic antiurolithiatic activity. Standard drug Cystone (p = 
0.013), Sida acuta at 200 mg/kg (p = 0.016) and 400 mg/kg (p = 
0.013) showed significant decrease in crystal deposition around 
zinc disc as compared to control but with Sida acuta at 100 
mg/kg (p = 0.109) the difference was not statistically significant. 
There was no statistically significant difference between the 
median weights of deposit around zinc discs in the Cystone and 
Sida acuta 200 mg/kg (p = 0.337), 400 mg/kg (p = 0.575) 
groups.  
Results of testing for curative antiurolithiatic property among 
different treatment groups are given in table 4. There was no 
statistically significant difference between control, Cystone and Sida 
acuta at three different doses (100 mg/kg, 200 mg/kg, 400 mg/kg) 
for the curative effect on urinary stones (p = 0.587). 
 
Table 3: Prophylactic activity of Sida acuta root extract on crystal deposition around zinc disc 
Group Deposit weight in mg [Median (Q1, Q3)] p value 
Control 133 (91.5, 240.25) - 
Cystone 750 mg/kg 47 (21.25, 88.50) 0.013* 
Sida acuta 100 mg/kg 86.5 (30, 127.25) 0.109 
Sida acuta 200 mg/kg 59 (48, 80.25) 0.016* 
Sida acuta 400 mg/kg 58.5 (27.5, 89.25) 0.013* 
* = p<0.05 as compared to control (Mann-Whitney test); n (number of rats) = 6 in each group 
 
Table 4: Curative activity of Sida acuta root extract on crystal deposition around zinc disc 
Group Deposit weight in mg [Median (Q1, Q3)] 
Control 168 (38.75, 398.5) 
Cystone 750 mg/kg 81.50 (12, 137.75) 
Sida acuta 100 mg/kg 97 (90.50, 119.75) 
Sida acuta 200 mg/kg 99 (30.50, 131.75) 
Sida acuta 400 mg/kg 57.5 (16.75, 141.75) 
p = 0.587 (Kruskal-Wallis test); n (number of rats) = 6 in each group 
 
DISCUSSION 
This study evaluated the diuretic and antiurolithiatic activity of 
orally administered ethanolic root extract of Sida acuta Burm. f. in 
normal albino Wistar rats. Sida acuta was selected for the study 
since it has been used for the same purpose in traditional medicine 
and in in vitro studies. Furosemide, a widely used diuretic, was used 
as the reference diuretic and Cystone was used as the standard 
antiurolithiatic drug. All the drugs were administered orally, since 
oral route is the most common route of drug administration, 
especially with traditional herbal medicine. 
Diuretics are drugs that increase the rate of urine flow. Clinically 
useful diuretics also increase the excretion rate of Na+ion, which is a 
major determinant of extracellular fluid volume. Furosemide acts by 
inhibiting Na+-K+-2Cl- symporter and thereby, interfering with their 
absorption [17]. 
Even though Sida acuta is said to possess diuretic activity [7, 18], no 
study has been published till date to validate the diuretic activity of 
ethanolic extract of its root, to the best of our knowledge. 
In the present study, although all the test groups showed an increase 
in urine output as compared to the control, the increase was 
significant only with high dose Sida acuta (400 mg/kg). The diuretic 
activity is considered to be good when the diuretic index values are 
higher than 1.50, moderate when the values are between 1.00 to 
1.50, mild when the values are from 0.72 to 1.00 and no diuretic 
activity exists with values below 0.72 [19]. Both furosemide group 
and Sida acuta 400 mg/kg group showed a diuretic index 
value>1.50, indicating good diuretic activity. 
Furosemide produced a significant increase in the excretion of all 
the three major urinary electrolytes, Na+, K+ and Cl- with respect to 
control. This shows its saluretic capacity. All the three doses of Sida 
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acuta produced a dose-dependent increase in the excretion of Na+, 
K+ and Cl-. However, significance was noted with respect to K+ 
excretion in all the groups, and Cl-excretion in medium (200 mg/kg) 
and high dose (400 mg/kg) of the test drug. This probably indicates 
a different mode of action for Sida acuta compared to furosemide. 
The mineral content of herbs can also be a confounding factor 
contributing to the diuretic effect of plant extracts. Plant extracts 
with diuretic activity were observed to have a high ratio of 
potassium to sodium content [20]. Hook et al., in a study conducted 
with dandelion, concluded that its high potassium content was 
responsible for the diuretic activity [21]. Herbal diuretics without 
significant action on the excretion of urinary electrolytes are 
considered aquarectics [22]. Increased urine output by aquarectics 
may prove to be beneficial in kidney stones, and for the treatment of 
mild urinary infections [22]. Na+/K+ ratio greater than 10.0 indicate 
potassium sparing effect [23]. Since all the treatment groups had 
lesser values, potassium-sparing action can be ruled out. 
Zinc disc implantation induced urinary bladder calculi model is one 
of the commonly used models for preclinical evaluation of the 
antiurolithiatic activity. This model induces urinary calculi without 
severe renal damage and mimics the etiology of stone formation in 
humans. The main component of crystals formed is magnesium 
ammonium phosphate [16]. Ethylene glycol administration 
following zinc disc implantation promotes the development of CaOx 
crystals [24]. Vimala et al., demonstrated the in vitro inhibitory effect 
on CaOx crystal growth by aqueous and methanolic extracts of roots 
of Sida acuta [9]. 
There was a high degree of variation in the size of stones formed in 
all the treatment groups. Test for prophylactic antiurolithiatic 
activity showed a significant decrease in crystal deposition with a 
medium and high dose of Sida acuta, which was comparable with 
standard drug Cystone. This confirms the potential of Sida acuta as a 
prophylactic antiurolithiatic agent. The diuretic action of the extract 
could have led to the inhibition of stone formation.  
Due to very high intra-group variation in stone sizes among rats 
tested for curative antiurolithiatic activity, there was no statistically 
significant difference between the groups. However, median weight 
of stones in the different groups displayed a trend towards dose-
dependent curative effect on the formed stones. High variation in 
stone size could be due to physiological variation among individual 
rats or due to the long duration of the study. Singh et al., 
demonstrated that there is sufficiently large depositions around zinc 
discs even within 10 d of implantation [25]. They also showed that 
the rats suffer from severely compromised renal functions due to 
increasing crystal size for studies beyond 20 d [25], which may further 
promote the development of large stones. Further studies, either of a 
shorter duration or using other models, need to be conducted to 
evaluate the complete antiurolithiatic potential of Sida acuta. 
Oxalate, one of the commonest ion implicated in urolithiasis, is 
known to produce renal tubular epithelial cell death by oxidative 
stress, and may promote the formation of stones [26, 27]. Londonkar 
et al., identified the presence of various alkaloids, steroids, 
carbohydrates, glycosides, amino acids, saponins, flavonoids, 
anthocyanins, fatty acids and phenolic compounds in the ethanolic 
extract of Sida acuta Burm. f [28]. Many of these compounds are 
known to possess antioxidant activity, and may have a protective 
effect in urolithiasis [29, 30]. Hence, further research is needed to 
identify the exact compound in Sida acuta responsible for its diuretic 
and antiurolithiatic activity. 
CONCLUSION 
Even though Sida acuta showed significant diuretic activity, with the 
high dose (400 mg/kg) being almost equivalent to furosemide in 
increasing urine output, it didn’t produce a significant increase in 
the excretion of major urinary electrolyte, sodium. Hence, it can be 
considered to be an aquarectic rather than a diuretic. Sida acuta also 
showed significant activity as a prophylactic antiurolithiatic agent, 
with the higher dose being almost equi-efficacious as Cystone. 
However, the results were inconclusive when tested for curative 
anturolithiatic activity. Further studies are required to evaluate 
completely the antiurolithiatic potential of Sida acuta Burm. f. and 
the active constituents responsible for the same. 
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